All UK & Rest of Europe articles – Page 26
-
NewsMedications leave lasting mark on the gut microbiome, even years after use
Analysing stool samples and prescription records from over 2,500 Estonian Biobank participants, researchers found that the majority of drugs studied were linked to microbiome changes, with a substantial number of them also showing long-term effects detectable years after patients stopped taking them.
-
NewsMicrobial allies: Bacteria help fight against cancer
An international team of scientists have discovered that microbes associated with tumours produce a molecule that can control cancer progression and boost the effectiveness of chemotherapy.
-
NewsUS COVID-19 school closures were not cost-effective - but other non-pharmaceutical interventions were
School closures during the COVID-19 pandemic imposed enormous long-term costs while other measures delivered better health outcomes for far less money, according to new research analysing non-pharmaceutical interventions in the United States.
-
NewsAcross eight Amazon countries, forests on Indigenous lands reduce spread of 27 diseases
New research finds that municipalities in the Amazon region closest to healthy forests on Indigenous lands face less risk from rising cases of two categories of disease: cardiovascular and respiratory diseases due to forest fires and illnesses.
-
NewsIt’s not hopeless: Scientists want to learn lessons from climate change communication to save our soil
Soil scientists have urged us all to play our part in protecting our soil and to heed the lessons learnt from those who have been championing actions to mitigate the effects of climate change.
-
NewsMolecular Sustainable Solutions receives investment from BeAble Capital to boost disinfection and sterilization methods
Molecular Sustainable Solutions, a spin-off from the Universitat Jaume I of Castelló (UJI), secures €186,000 investment from BeAble Capital, a leading Science Equity fund specializing in disruptive scientific technologies.
-
NewsSwitching disease on and off: How a gene switch could help against bacterial infections
Researchers show how bacteria actively switch off their disease-causing mechanisms at high cell density and evade the immune system – a potential key to fighting infections better.
-
NewsJames Hutton Limited awarded almost £39,000 to develop innovation campus
James Hutton Limited, the commercial wing of The James Hutton Institute, has been awarded £38,881 from the Scottish Government to progress a clima-tech and agri-tech innovation campus at its Invergowrie site.
-
NewsLiving cement: scientists turn bacteria-infused cement into energy-storing supercapacitors
By integrating electricity-generating microbes into cement, researchers have created a living supercapacitor that can store electricity and regenerate its capacity. The technology could pave the way for energy-autonomous buildings and infrastructure.
-
NewsDiet rich in vegetable protein and fiber helps maternal and infant health during pregnancy and breastfeeding
A Mediterranean-style diet, rich in fibre, vegetable proteins and healthy fats, benefits maternal health during pregnancy and breastfeeding. It prevents fat accumulation and optimizes the composition of the microbiota in the digestive system.
-
NewsScientists report the first use of CRISPR activation to treat a cardiac disease in mice
Researchers have demonstrated for the first time that CRISPR-based gene activation (CRISPRa) can be used to treat genetic heart disease in vivo. The study paves the way for novel targeted therapies for patients with genetic cardiac disorders.
-
NewsDrug-resistant fungus Candidozyma auris confirmed to spread rapidly in European hospitals: ECDC calls for urgent action
The latest ECDC survey shows that case numbers are rising and outbreaks are growing in scale, with several countries reporting ongoing local transmission.
-
NewsA ‘universal’ therapy against the seasonal flu? Antibody cocktail targets virus weak spot
Researchers report that a cocktail of antibodies protected mice—including those with weakened immune systems—from nearly every strain of influenza tested, including avian and swine variants that pose pandemic threats.
-
News‘Microbial piracy’ uncovers new way to fight drug-resistant infections
Researchers have discovered how ‘pirate phages’ hijack other viruses to break into bacteria, sharing new genetic material for dangerous traits.
-
NewsGut microbiome influences proteins that drive aging and disease
Scientists have uncovered new associations between gut microbiome and the aging process. The researchers found that certain microbial characteristics may causally influence proteins in the blood linked to inflammation and heart health.
-
NewsMushroom chemical teams with phages to deliver a one-two punch to MRSA
A chemical found in mushrooms can be teamed with bacteriophages to deliver a one-two punch to antibiotic-resistant infections, reveals a study presented at MLS Future Forum 2025.
-
NewsEven healthy children can be severely affected by RSV
It is not only premature babies and children with underlying diseases who suffer from serious respiratory syncytial virus (RSV) infections. Even healthy, full-term babies are at significant risk of intensive care or prolonged hospitalisation – especially during the first three months of life.
-
NewsA survival kit for smallpox viruses
Scientists have discovered a previously unknown type of assembly chaperone during their analysis of poxviruses, and they have decoded its function in full detail. This is the first known chaperone that is not formed by a protein but by a nucleic acid — specifically RNA.
-
NewsRoutine Helicobacter pylori screening does not significantly reduce upper gastrointestinal bleeding in patients after a heart attack
Routine Helicobacter pylori screening did not significantly reduce the risk of upper gastrointestinal bleeding in patients hospitalised for myocardial infarction (MI), according to new research.
-
NewsDNA analysis shows colorectal cancer has unique microbial fingerprint
Colorectal cancer is unique in having its own microbial ‘fingerprint’ – according to new research that could help doctors better understand how this cancer develops, how aggressive it might be, and even how a patient might respond to treatment.